Capital Fund Management (CFM)
MIRM icon

Capital Fund Management (CFM)’s Mirum Pharmaceuticals MIRM Stock Holding History

Capital Fund Management (CFM)’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,638
Closed -$1.81M – 2275
2026
Q1 		$1.81M Sell
19,638
-42,675
-68% -$4.01M 0.01% 1408
2025
Q4 		$4.92M Buy
62,313
+26,198
+73% +$1.88M 0.01% 1200
2025
Q3 		$2.65M Buy
36,115
+6,840
+23% +$435K 0.01% 1633
2025
Q2 		$1.49M Sell
29,275
-5,852
-17% -$261K ﹤0.01% 1831
2025
Q1 		$1.58M Buy
35,127
+7,805
+29% +$368K ﹤0.01% 1513
2024
Q4 		$1.13M Buy
+27,322
New +$1.14M ﹤0.01% 1720

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Fund Management (CFM)'s MIRM Position: Q2 2026 in Review

Capital Fund Management (CFM) sold out of Mirum Pharmaceuticals (MIRM) in Q2 2026, closing a stake of 19,638 shares — an estimated $1.81M sold.

Capital Fund Management (CFM) first reported a position in MIRM in Q4 2024 and held it in 6 quarters. The position peaked at $4.92M in Q4 2025. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Capital Fund Management (CFM) reported no remaining Mirum Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 19,638 Mirum Pharmaceuticals shares in Q2 2026, an estimated $1.81M.
  • Capital Fund Management (CFM) first reported a position in Mirum Pharmaceuticals in Q4 2024 and held it in 6 quarters.
  • Capital Fund Management (CFM)'s Mirum Pharmaceuticals position peaked at $4.92M in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.